Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional
Official Title: Phase II Study Temozolomide for Retinoblastoma Metastatic to the Central Nervous System for Patients From Guatemala
Brief Summary:
Primary Objectives:
To investigate the response rate (complete response plus partial response) of temozolomide for 8 weeks (2 cycles), in patients with retinoblastoma metastatic to the central nervous system (mass only) in two strata:
Secondary Objectives: